Seeking Alpha

Retail Investor's  Instablog

Retail Investor
Send Message
Retail Investor, Shareholder Activist and Editor of Stocks DD blog. You are cautioned to read the disclaimer in Seeking Alpha before reading my articles. I am NOT a registered investment adviser. My articles are ONLY for informative purposes and should NOT be treated as investment advice. My... More
My blog:
Stocks DD
View Retail Investor's Instablogs on:
  • Funds Significantly Increase Shareholdings In Taro

    As Taro continues to deliver on adding shareholder value, funds have significantly increased their stake. After >120% increase in share price from last year, Taro in June 2014 announced significant price hikes; To read more, please click here

    Tags: TARO, PRGO, VRX, AGN, long ideas
    Aug 19 2:23 AM | Link | Comment!
  • TARO Pharma Receives ANDA Approval For Clobetasol Propionate

    TARO received ANDA Approval for Clobetasol Propionate on July 2nd as can be seen from the FDA's web site. There are only 2 generic suppliers for this product currently in USA. Actavis and TARO. Actavis had 6 month exclusivity which started in January 2012. Investors would recall that Actavis, a comparable peer of TARO, competes in a number of products with TARO. The product listing of TARO and Actavis can be found. Actavis was acquired by Watson in April 2012 at 14.8 TTM EBIDTA.

    The Worldwide 2010 sales for Clobetasol Propionate was ~$240m

    Combined USA annual brand sales of Clobex® Shampoo and Clobex® Topical Lotion totaled $89.9 million for the 12 months ending September 30, 2011, according to IMS Health.

    This is another product that we expect would materially add to the future earnings of TARO.

    Disclosure: I am long TARO.

    Jul 29 7:05 AM | Link | Comment!
Full index of posts »
Latest Followers


More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.